NEW YORK (Legal Newsline) — A stock holder is suing a Massachusetts dialysis service provider, alleging false and misleading representation.
Christine Gelsleichter filed a class action lawsuit, individually and on behalf of all other persons similarly situated on Aug. 31, in the U.S. District Court for the Southern District of New York against
American Renal Associates Holdings Inc. of Beverly, Massachusetts, Joseph A. Carlucci and Jonathan L. Wilcox,
alleging that they violated the Securities Exchange Act.
According to the complaint, Gelsleichter has suffered significant financial losses and damages due to the decline in the market value of American Renal's securities. The plaintiff alleges the defendants made materially false and misleading statements regarding the company’s business, operational and compliance policies, and was engaged in a fraudulent scheme to steer patients away from qualified for Medicare and Medicaid plans into more expensive Affordable Care Act.
Gelsleichter seeks a trial by jury, certification that this complaint is a proper class action, appointing of the plaintiff as a class representative and the plaintiff's counsel as lead counsel, compensatory damages, costs and expenses and all other relief.
She is represented by attorneys Jeremy A. Lieberman, J. Alexander Hood II and Marc C. Gorrie of Pomerantz LLP in New York, by Patrick V. Dahlstrom of Pomerantz LLP in Chicago, and by Michael Goldberg and Brian Schall of Goldberg Law PC in Los Angeles.
U.S. District Court for the Southern District of New York Case number 1:16-cv-06841